Skip to content

Women With Chest Pain and Normal Coronary Arteries Study

Women With Chest Pain and Normal Coronary Arteries Study: A Randomized Study of Medical Treatment and Therapeutic Lifestyle Changes

Status
Terminated
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00743197
Enrollment
3
Registered
2008-08-28
Start date
2008-05-31
Completion date
2010-05-31
Last updated
2023-12-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chest Pain

Keywords

coronary artery disease (CAD), chest pain, myocardial ischemia, endothelial function

Brief summary

The purpose of this study is to compare the effectiveness of standard medical therapy versus usual care in women with chest pain, coronary endothelial dysfunction and unblocked coronary arteries. Coronary endothelial dysfunction (CED) is a condition in which the layers of cells around the heart do not function properly and is believed to be key factor in the development of atherosclerosis (fat deposits in arteries). In addition, CED is associated with an increased risk for future cardiovascular events, such as heart attack and stroke. A coronary angiogram allows physicians to see if any of the arteries in the heart are blocked, usually by fatty plaque. In many instances, angiograms in women experiencing chest pain do not show evidence of coronary disease (free of significant plaque build-up). Currently, there is no standard of care treatment plan for patients with normal coronary arteries, despite symptoms of chest pain, and as a result these patients may not receive medical treatment. However, these women often return to their physicians more than once with chest pain and go through a similar battery of tests.

Detailed description

Endothelial function testing will be performed on women without significant coronary disease in order to help identify women who may be likely to develop coronary artery disease (CAD) and who would benefit from aggressive lifestyle (dietary counseling, exercise) or medical (treatment with aspirin and cholesterol and blood pressure lowering medications) interventions.

Interventions

DRUGAspirin

Aspirin 81 mg daily

DRUGLisinopril

Lisinopril 10 mg every night

DRUGSimvastatin

Simvastatin 20 mg every night

DRUGLovaza

Lovaza 1 gram daily

Therapeutic lifestyle changes will be initiated with the assistance of a dietician, including diet counseling, exercise recommendation, and weight maintenance/weight loss.

Sponsors

Astellas Pharma US, Inc.
CollaboratorINDUSTRY
Northwestern University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Age
30 Years to 90 Years
Healthy volunteers
No

Inclusion criteria

1. Female gender 2. Age 30 or greater 3. Present with symptoms suggestive of Angina (Typical or Atypical) 4. Abnormal myocardial perfusion scan 5. Referred for angiography 6. Normal (0% stenosis) versus Nonobstructive coronary artery disease (CAD) (\<50% stenosis) 7. Evidence of endothelial dysfunction.

Exclusion criteria

1. Coronary vasospasm known or documented in cardiac catheterization 2. Obstructive CAD (greater than 50% stenosis) known or documented in cardiac catheterization 3. Pregnancy 4. Established CAD, history of revascularization with percutaneous transluminal coronary angioplasty (PTCA)/stent or coronary artery bypass graft (CABG) 5. Contraindications to magnetic resonance imaging (MRI) 6. Cardiac catheterization for valvular disease 7. Cardiac catheterization for heart failure assessment/biopsy 8. Known congestive heart failure (CHF)/hypertrophic obstructive cardiomyopathy (HOCM)/dilated cardiomyopathy (DCM) 9. Acute Renal Failure 10. Chronic renal failure (estimated glomerular filtration rare (eGFR) \<30 ml/min/1.73m\^2) or on hemodialysis 11. Known single kidney 12. History of peptic ulcer disease, known gastrointestinal bleed, known contraindication to aspirin 13. Known contraindication to statin 14. Known contraindication to adenosine (asthma, high degree atrial ventricular (AV) block)

Design outcomes

Primary

MeasureTime frameDescription
Effectiveness of Therapy Compared to Usual Care, in Those Women With Chest Pain (CP), Reversible Ischemia by Stress Testing and Nonobstructive Coronary Artery Disease (CAD) by Angiography Who Are Found to Have Coronary Endothelial Dysfunction (CED).1 yearThe purpose of this study is to compare the effectiveness of standard medical therapy versus usual care in women with chest pain (CP), coronary endothelial dysfunction (CED) and unblocked coronary arteries. CED is a condition in which the layers of cells around the heart do not function properly and is believed to be a key factor in the development of atherosclerosis (fat deposits in arteries). In addition, CED is associated with an increased risk for suture cardiovascular events, such as heart attack and stroke.

Countries

United States

Participant flow

Participants by arm

ArmCount
Usual Care Group
USUAL CARE GROUP-therapy in this group will be no dictated medical therapy, but usual care, as dictated by their referring physician.
1
Medical Treatment Group
TREATMENT GROUP-therapy in this group will be conventional treatment for CAD but targeting endothelial function, which will include aspirin, ACE-inhibitor and statin therapy, and therapeutic lifestyle changes.
2
Total3

Withdrawals & dropouts

PeriodReasonFG000FG001
Overall StudyStudy terminated due to departure of PI.12

Baseline characteristics

CharacteristicUsual Care GroupMedical Treatment GroupTotal
Age, Categorical
<=18 years
0 Participants0 Participants0 Participants
Age, Categorical
>=65 years
0 Participants0 Participants0 Participants
Age, Categorical
Between 18 and 65 years
1 Participants2 Participants3 Participants
Region of Enrollment
United States
1 participants2 participants3 participants
Sex: Female, Male
Female
1 Participants2 Participants3 Participants
Sex: Female, Male
Male
0 Participants0 Participants0 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
— / —— / —
other
Total, other adverse events
0 / 10 / 2
serious
Total, serious adverse events
0 / 10 / 2

Outcome results

Primary

Effectiveness of Therapy Compared to Usual Care, in Those Women With Chest Pain (CP), Reversible Ischemia by Stress Testing and Nonobstructive Coronary Artery Disease (CAD) by Angiography Who Are Found to Have Coronary Endothelial Dysfunction (CED).

The purpose of this study is to compare the effectiveness of standard medical therapy versus usual care in women with chest pain (CP), coronary endothelial dysfunction (CED) and unblocked coronary arteries. CED is a condition in which the layers of cells around the heart do not function properly and is believed to be a key factor in the development of atherosclerosis (fat deposits in arteries). In addition, CED is associated with an increased risk for suture cardiovascular events, such as heart attack and stroke.

Time frame: 1 year

Population: no analyses were conducted due to PI's departure from institution;all work including analyses ceased upon departure-the study was not transferred with the PI. In addition, study end points were based on changes between groups (treatment vs. usual care)at 12-mo follow up for both groups- none of the enrolled subjects completed the month 12 visit.

Comparison: 0

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026